Sage Journals: Discover world-class research

Retricted access

Research article

First published 2008-04

Update: Improvement Strategies for Peptide Receptor Scintigraphy and Radionuclide Therapy

Monique de Visser, Suzanne M. Verwijnen, Marion de Jong

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Review article

First published 2015-03

Peptide Receptor Radionuclide Therapy: An Overview

Ashutosh Dash, Sudipta Chakraborty, Maroor Raghavan Ambikalmajan Pillai [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Brief report

First published 2021-6

Severe metabolic acidosis and hyperkalemia after peptide receptor radionuclide therapy. A case report,review of the literature and proposed treatment algorithm

Nikolaos A Trikalinos, Hyun Kim, Amir Iravani [...]

Journal of Onco-Nephrology

Retricted access

Research article

First published 2010-10

Renal Dosimetry in Peptide Radionuclide Receptor Therapy

Jeffry A. Siegel, Michael G. Stabin, Robert M. Sharkey

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Review article

First published 2016-08

Myelotoxicity of Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Decade of Experience

Murali Kesavan, J. Harvey Turner

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2014-06

Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature

Fabio Minutoli, Ernesto Amato, Alessandro Sindoni [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2007-06

Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with 177 Lu DOTA-TATE and 177 Lu DOTA-NOC

Christiane Wehrmann, Stefan Senftleben, Carolin Zachert [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2009-12

Lymphocytic Toxicity in Patients After Peptide-Receptor Radionuclide Therapy (PRRT) with 177 Lu-DOTATATE and 90 Y-DOTATOC

Maribel L. Sierra, Alberto Agazzi, Lisa Bodei [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2016-08

Sensitivity Analysis of a Physiologically Based Pharmacokinetic Model Used for Treatment Planning in Peptide Receptor Radionuclide Therapy

Deni Hardiansyah, Nusrat Jihan Begum, Peter Kletting [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2012-11

Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177 Lu-DOTATATE

Santosh K. Gupta, Suhas Singla, Chandrasekhar Bal

Cancer Biotherapy and Radiopharmaceuticals

Search results